A team of researchers has used advanced DNA sequencing to develop the most comprehensive atlas yet of genetic change through generations, laying the foundations for new insights into the roots...
Research has found that C. difficile, one of the most common and contagious hospital-acquired infections, spreads more than three times more than previously thought, moving covertly from surface to surface...
On March 29, 2025, the University of Utah received a revised Notice of Award from the National Center for Advancing Translational Sciences restoring funding to the UM1 grant supporting the...
The results could ultimately help doctors reduce the risk of type 1 diabetes—or potentially even restore lost metabolic function in adulthood—by providing gut microbes that help the pancreas grow and...
There may be up to a tenfold difference in risk for infants who are currently treated identically under clinical guidelines. The analysis is an important step toward more personalized pregnancy...
The drug lenacapavir, developed by Gilead Sciences, provides protection for half a year instead of one day and has performed extremely well in clinical trials.
Synthetic organisms, mirror-reversed on the molecular level from natural life, could be a possibility within decades. They could interact with humans and the environment in unpredictable, potentially dangerous ways.
The therapy increases the amount of blood the heart can pump and dramatically improves survival, in what a paper describing the results calls “an unprecedented recovery of cardiac function.”
NASA crew and ground-based scientists are sending blood cells to the International Space Station on November 4 to learn why astronauts have a higher risk of blood clots.
University of Utah Health approached a half-billion dollars ($492.3 million) in research funding in fiscal year 2024. Research in the health sciences has been on a growth trajectory more than...
